Enzyme Linked Immunosorbent Assay (ELISA) Market - by Method (Direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA), by Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring & Pharmaceutical Industry & Transplantation), By Technology (Chemiluminescent, Colorimetric, & Fluorescent), and by Region - Global Industry Insights, and Forecast till 2025

  • Published On : Apr 2018 |
  • Pages : 170 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Enzyme Linked Immunosorbent Assay (ELISA) Market – Creating Substantial Growth in Medical Diagnostics

Enzyme Linked Immunosorbent Assay (ELISA) is most commonly performed immunoassay that is used to identify proteins, peptides, antibodies, and hormones. ELISA has application in the field of biotechnology medicine as a diagnostic tool that is attributed by a color change in order to identify a target substance and measure its concentration in the test sample. The common diagnostic applications of ELISA includes HIV infection, pregnancy tests, and measurement of cytokines, soluble proteins, and others. Various antigen-antibody combinations are used in the immunoassay that include an enzyme-labeled antigen or antibody and enzyme activity is measured. Depending on the antigen-antibody combination, the assay is called a direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA. High prevalence of infectious disease such as HIV and increasing awareness regarding diagnosis of cancer and autoimmune diseases are major factors propelling demand for ELISA to reduce the burden of chronic diseases with early and accurate disease diagnosis. For instance, According to Centers of Disease Control & Prevention (CDC), 2014, number of patients infected with HIV in the U.S. was 37,600. The CDC also reported a decline of 10% in the incidence rate of HIV as compared to 2010, owing to early detection and advanced diagnostic.

The global Enzyme Linked Immunosorbent Assay (ELISA) Market was valued at US$ 1,583.4 million in 2017 and is expected to witness a robust CAGR of 5.1% over the forecast period (2017 - 2025).

Figure 1. Global Enzyme Linked Immunosorbent Assay (ELISA) Market in (US$ Mn), by Region, 2017

elisa market

Source: Coherent Market Insights (2018)

Factors such as increasing incidence of infectious diseases and cancer coupled with increasing demand for cost-effective diagnostic tools are expected to drive growth of the Enzyme Linked Immunosorbent Assay (ELISA) market. According to the Centers of Disease Control & Prevention (CDC), 2015, the number of visits to physician offices for infectious and parasitic diseases in the U.S. was 16.8 million. Furthermore, vector borne diseases comprise a major percentage of infectious diseases and affects a wide population. According to the World Health Organization (WHO), 2017, annually vector borne diseases accounts for over 17% of all infectious diseases causing over 700,000 deaths worldwide. Dengue is most commonly occurring vector borne disease with around 96 million new cases diagnosed annually. Moreover, advancements in the technology of ELISA are also fueling the market growth. For instance, in August 2017, researchers at University of Illinois, Urbana Campaign, developed a portable spectral analyzer based on ELISA assay that enables a smartphone to perform lab grade medical diagnostic tests, which usually requires expensive instruments. This test includes detection and measurement of variety of proteins and antibodies in blood, urine, and saliva samples that is commonly used for wide range of clinical diagnostic tests. Apart from the conventional medical applications such as disease diagnosis and transplantation, ELISA can also be used in the field of toxicology for determination of certain classes of drugs that is expected to aid the market growth in near future. However, cross reactivity leading to false positive and false negative results exhibited by the tests leading to incorrect diagnosis can obstruct the market growth. For instance, according to study report published by American Medical Association 2011, the preliminary health department data identified 32 pregnant women with HIV positive through ELISA assays. However, after a confirmatory test, 17 of these women were confirmed to be negative for HIV virus.

In terms of region, North America dominated the global Enzyme Linked Immunosorbent Assay (ELISA) Market. This is attributed to development of innovative products by manufacturers in the region. For instance, in January 2018, Eagle Biosciences, Inc. introduced a novel intact FGF23 ELISA kit assay, which is a 96 well Sandwich ELISA assay. It measures the full length active form of Human Intact FGF23 used for the detection of Mineral Bone Disorder, Chronic Kidney Disease, Tumor induced Osteomalacia, and hyperphosphatemia. Moreover, various private and public sectors carrying out research and development in Immunoassay-based clinical diagnostics are commercializing their research inventions by collaborating with existing market players to introduce new products in the market. For instance, in March 2018, BARD1 Life Sciences, U.S-based Science Research Company is expected to commercialize its BARD1-Ovarian blood based ELISA test to identify ovarian cancer in early stages. Furthermore, Asia Pacific is projected to be the fastest growing region in ELISA market, owing to geographical expansion of regional players along with introduction of novel enzyme-based test kits at affordable prices. For instance, in January 2017, Fujirebio, a Japan-based IVD diagnostic testing company introduced Lumipulse G β-Amyloid 1-42 ELISA assay in Europe that facilitates quantitative measurement of β-amyloid1-42 in human cerebrospinal fluid within of 30 minutes.

Market players are engaged in development of innovative products to maintain leading position in global Enzyme Linked Immunosorbent Assay (ELISA) Market

The key players are developing novel, innovative, and smart products to maintain leading position in the Enzyme Linked Immunosorbent Assay (ELISA) Market. For instance, in January 2017 Illumina, Inc. and Bio?Rad Laboratories, Inc. introduced the Illumina Bio-Rad Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference, San Francisco. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic responses. Moreover, in 2015, Enzo Life Sciences introduced new VEGF ELISA Kit, an ultra-sensitive assay as competitive detection method for measuring VEGF in serum, plasma, and cell culture supernatants that measures as little as 4 pg /ml of VEGF and provide quantitative results.

Key players operating the global Enzyme Linked Immunosorbent Assay (ELISA) Market include Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.

Enzyme Linked Immunosorbent Assay (ELISA) is one of the promising techniques used for the detection and quantification of biological analytes such as peptides, proteins, antibodies, and hormones. This technique can be useful to provide a quick and cost-effective assay to measure the concentration of unknown antigen or antibody in a specific analyte. ELISA finds its extensive application as a diagnostic tool in medicines as well as to monitor and quality check-up procedures in drug development processes at various industries. ELISA can be performed by different type of methods that include direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA. The high sensitivity, flexibility and cost effectiveness of indirect ELISA makes it an ideal choice of most of the test kit manufacturers and thus possess the highest market share.

Market Dynamics

The Enzyme Linked Immunosorbent Assay (ELISA) Market is expanding owing to the increasing incidence of chronic diseases mainly in case of infectious diseases, vector borne diseases and cancer. According to the National Cancer Institute, cancer has a major impact on the population of U.S. and across the world. The NCI reports approximately 1,685,210 new cases of cancer were diagnosed in 2016. Also, reports demand for efficient detection tests that can be sufficed with the help of ELISA test kits. Moreover, increasing demand for cost-effective diagnostic tool is one of the factor aiding the growth of ELISA market, especially in the low and middle income economies. For instance, in October 2017, the Nigerian government and World Health Organization (WHO) launched a campaign to vaccinate around 874,000 people against yellow fever in two states of the country Kwara and Kogi in alliance with the International Coordination Group. The samples of the patients suspected with yellow fever were further tested with the help of ELISA test at the Pasteur Institute in Dakar. However, availability of alternate immunoassays and cross reactivity projected by these tests can hinder the market growth. Development of cost-effective ELISA tests with improved reliability and accuracy can provide potential opportunity for market players to strategize their growth in the global ELISA market.

Key features of the study:

  • This report provides in-depth analysis of Enzyme Linked Immunosorbent Assay (ELISA) Market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global Enzyme Linked Immunosorbent Assay (ELISA) Market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study includes Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global Enzyme Linked Immunosorbent Assay (ELISA) Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the Enzyme Linked Immunosorbent Assay (ELISA) Market

Detailed Segmentation:

  • Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method:
    • Direct ELISA
    • Indirect ELISA
    • Sandwich ELISA
    • Competitive ELISA
  • Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Application:
    • Vaccine Development
    • Immunology
    • Diagnostics
    • Toxicology
    • Drug Monitoring & Pharmaceutical Industry
    • Transplantation
  • Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Technology:
    • Chemiluminescent
    • Colorimetric
    • Fluorescent
  • Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Geography:
    • By Method:
      • Direct ELISA
      • Indirect ELISA
      • Sandwich ELISA
      • Competitive ELISA
    • By Application:
      • Vaccine Development
      • Immunology
      • Diagnostics
      • Toxicology
      • Drug Monitoring & Pharmaceutical Industry
      • Transplantation
    • By Technology:
      • Chemiluminescent
      • Colorimetric
      • Fluorescent
    • By Country:
      • U.S.
      • Canada
    • North America
    • Latin America
      • By Method:
        • Direct ELISA
        • Indirect ELISA
        • Sandwich ELISA
        • Competitive ELISA
      • By Application:
        • Vaccine Development
        • Immunology
        • Diagnostics
        • Toxicology
        • Drug Monitoring & Pharmaceutical Industry
        • Transplantation
      • By Technology:
        • Chemiluminescent
        • Colorimetric
        • Fluorescent
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    •  Europe
      • By Method:
        • Direct ELISA
        • Indirect ELISA
        • Sandwich ELISA
        • Competitive ELISA
      • By Application:
        • Vaccine Development
        • Immunology
        • Diagnostics
        • Toxicology
        • Drug Monitoring & Pharmaceutical Industry
        • Transplantation
      • By Technology:
        • Chemiluminescent
        • Colorimetric
        • Fluorescent
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Method:
        • Direct ELISA
        • Indirect ELISA
        • Sandwich ELISA
        • Competitive ELISA
      • By Application:
        • Vaccine Development
        • Immunology
        • Diagnostics
        • Toxicology
        • Drug Monitoring & Pharmaceutical Industry
        • Transplantation
      • By Technology:
        • Chemiluminescent
        • Colorimetric
        • Fluorescent
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Method:
        • Direct ELISA
        • Indirect ELISA
        • Sandwich ELISA
        • Competitive ELISA
      • By Application:
        • Vaccine Development
        • Immunology
        • Diagnostics
        • Toxicology
        • Drug Monitoring & Pharmaceutical Industry
        • Transplantation
      • By Technology:
        • Chemiluminescent
        • Colorimetric
        • Fluorescent
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Method:
        • Direct ELISA
        • Indirect ELISA
        • Sandwich ELISA
        • Competitive ELISA
      • By Application:
        • Vaccine Development
        • Immunology
        • Diagnostics
        • Toxicology
        • Drug Monitoring & Pharmaceutical Industry
        • Transplantation
      • By Technology:
        • Chemiluminescent
        • Colorimetric
        • Fluorescent
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Bio-Rad Laboratories, Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Market Strategies
    • Thermo Fisher Ssienctific, Inc.
    • ALPCO
    • BioLegand, Inc.
    • Biomerieux S.A.
    • Enzo Life Sciences, Inc.
    • Zeus Scientific, Inc.
    • Shenzen YHLO Biotech Co. Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Method
      • Market Snippet, By Application
      • Market Snippet, By Technology
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Product Launches
    • Mergers and Acquisitions
    • Market Trends
    • Porter’s Five Forces Analysis
    • Alternative Immunoassays for Disease Diagnostics
    • Epidemiology
  4. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method, 2015 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Direct ELISA
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Indirect ELISA
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Sandwich ELISA
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Competitive ELISA
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
  5. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Application, 2015 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Vaccine Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Immunology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Toxicology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Drug Development & Pharmaceutical Industry
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Transplantation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
  6. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Technology, 2015 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Chemiluminescent
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Colorimetric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    • Fluorescent
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
  7. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Region, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, For Region, 2016 – 2025
    • North America
      • Market Size and Forecast, By Method, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Technology, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Method, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Technology, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Method, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Technology, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Method, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Technology, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Method, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Technology, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Method, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Technology, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Thermo Fisher Scientific, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • ALPCO
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • BioLegand, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Biomerieux S.A.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Enzo Life Sciences, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Zeus Scientific, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Shenzhen YHLO Biotech Co. Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
  9. Section
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 42 market data tables and 36 figures on "Enzyme Linked Immunosorbent Assay (ELISA) Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.